Life Epigenetics, GWG Holdings’ Insurtech Subsidiary, Releases Infographic Timeline of the Impact of Epigenetics on the Ins...
December 07 2017 - 4:30PM
Life Epigenetics, the insurtech subsidiary of GWG Holdings,
Inc. (Nasdaq:GWGH), released an infographic timeline of the
impact of epigenetics on the insurance industry.
The timeline shows how the Human Genome Project sparked research
that led to the discovery of mortality prediction technology. Life
Epigenetics holds the exclusive license for lifespan-predictive
technology developed at the University of California, Los Angeles
(UCLA) for the life insurance industry.
The infographic is being released as a follow-up to a webinar
company executives Jon Sabes and Brian Chen participated in with
IRIS.xyz and ETF Trends titled “Technology that Disrupts the Life
Insurance Industry.” IT is available at this link.
The webinar is now available on replay to qualified financial
professionals at this link: IRS.xyz/ETF Trends Webinar link
Since February, Life Epigenetics has been collecting and
analyzing data from life insurance policyholders and has been
discussing its work with major life insurance and reinsurance
companies that have expressed interest in learning more about how
the technology can add value to their businesses. In October,
it has announced pilot programs with two life insurance companies
to test its epigenetic-based M-Panel technology.
About Life Epigenetics
Life Epigenetics is the insurtech subsidiary of GWG Holdings,
Inc. (Nasdaq:GWGH) that is dedicated to creating new technology
that is transformative to the way life insurance and financial
services underwrite and deliver longevity-based products and
services. The company’s “DNA methylation-based predictor of
mortality technology,” exclusively licensed from the University of
California, Los Angeles (UCLA), provides unprecedented new insight
into longevity using the cutting edge science of epigenetics.
For more information about Life Epigenetics, Inc.,
visit www.lifeegx.com
About GWG Holdings, Inc.
GWG Holdings, Inc. (Nasdaq:GWGH) is a financial services company
committed to transforming the life insurance industry through
disruptive and innovative products and services. The company owns
Life Epigenetics and GWG Life. GWG Life is developing a suite of
new longevity-based products for consumers and financial advisors
under the LifeCare Xchange (LCX). The LifeCare Xchange provides
consumers owning life insurance with the opportunity to exchange
their life insurance into products that can be used to pay for
long-term care and meet other retirement financial needs. Life
Epigenetics is developing transformative M-Panel epigenetic
technology to disrupt traditional life insurance underwriting
practices. Since 2006, GWG Life has provided seniors over $457
million in exchange value for their life insurance and, as of
September 30, 2017, owns a portfolio of over $1.62 billion in face
value of policy benefits.
For more information about GWG Holdings, Inc.
email info@gwglife.com or visit www.gwgh.com.
Media Contact:
Dan Callahan Director of Communication GWG Holdings, Inc. (612)
746-1935 dcallahan@gwglife.com
Attachments:
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/dde54384-d281-4869-ad5c-6aacb4427777
Attachments:
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/da5324b7-b118-414a-bbb6-6914715ce2c9
Daniel T Callahan
GWG Life
612-746-1935
callahad@gmail.com
GWG (NASDAQ:GWGH)
Historical Stock Chart
From Mar 2024 to Apr 2024
GWG (NASDAQ:GWGH)
Historical Stock Chart
From Apr 2023 to Apr 2024